Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-24 @ 11:14 PM
NCT ID: NCT06110156
Eligibility Criteria: Inclusion Criteria: * Patients will be invited to enroll in the study if they are in the top decile of risk selected by a risk prediction model of polypharmacy-related adverse events. The risk prediction model includes variables such as: age, sex, recent healthcare encounters, current and past medications, current and past lab tests, current and past diagnoses. * 65 years of age or older * Have a primary care clinician within the Cedars-Sinai Health System who uses MyCSLink (electronic health record used by Cedars-Sinai). * Part of a Cedars-Sinai Health System population health registry (e.g., enrolled in an Accountable Care Organization, Medicare Advantage plan, or Primary Care First program) * Diagnosis of Mild Cognitive Impairment or Dementia at baseline (for one intervention group) on the problem list Exclusion criteria include: * Patients for whom there is an active substance use disorder (defined by a physician) and thus for whom the intervention may not be appropriate * Patients with an organ transplant * Visits with a Cedars-Sinai Medical Center pharmacist for a polypharmacy consult within the last 6 months * Patients who previously indicated in the EHR that they wish to opt out of participating in research studies. * Patients enrolled in CS360, a program for highly complex medical patients, who already receive polypharmacy services.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 65 Years
Study: NCT06110156
Study Brief:
Protocol Section: NCT06110156